People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Mounjaro and Ozempic are two medications that can help with diabetes and weight management. But is there a winner in the ...

Investors are worried Novo Nordisk's competition with Eli Lilly is heating up and that the first-to-market GLP-1 leader is ...

Hims & Hers stock has surged due to impressive quarterly results, rapid weight-loss product expansion, and a strategic Novo ...

From a celebrity-spruiked success to a relic of diet culture. How a changing world of nutrition led to Weight Watchers' bankruptcy.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A new generation of GLP-1 drugs promising fast results continues to rock the weight loss industry, which has emphasized ...

A man is suing the manufacturers of Ozempic, alleging the diabetes drug caused him to go blind. The medication, containing ...

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

Here is what can happen to the body once you finish a course of Ozempic as a simulation reveals what the diabetes drug does ...

Just today, this drug became more widely available. Some product is now facing a recall following an apparent storage error.